Medical Device and Diagnostic Industry (MD+DI)

Pulse Biosciences Data Shows Advantage in PFA Technology That Could Disrupt Billion Dollar AFib Market

Pulse Biosciences is positioning its nanosecond PFA technology as a game-changer in the competitive atrial fibrillation ...
AZ Central

Exploring Pulse Manual Soldering Technology: From EWM Benchmark to the Rise of Domestic Brands

WENZHOU, ZHEJIANG, CHINA, April 3, 2026 /EINPresswire.com/ — Imagine welding paper-thin stainless steel without a trace of distortion, or perfectly fusing joints ...
Rutland Herald

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation™ (nsPFA™) energy, today announced that its nPulse™ Cardiac Catheter will be ...
Business Wire

Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...